A modern board for a new era of medicine — advancing education, certification, and clinical standards for physicians practicing genomics-driven, data-informed, individualized care.
Setting the benchmark for next-generation clinical practice.
Clinical Focus Areas
Rapid growth in genomics, diagnostics, and AI-driven healthcare is creating a defining opportunity for physicians trained in precision medicine — across certification, research, education, and governance.
Precision medicine can no longer rely on one-size-fits-all care. ABOPM certification is grounded in the disciplines that make modern medicine more targeted, more predictive, and more biologically aligned.
These pillars work together to move medicine beyond generalized treatment and toward a rigorous model of care that integrates biology, computation, and clinical decision-making.
Harness genomic, transcriptomic, proteomic, and metabolomic data to understand individual disease risk, biology, and treatment response with greater depth and specificity.
Learn MoreMove beyond isolated pathways to understand disease as a dynamic system, enabling prediction, prevention, and precision intervention across interconnected biological networks.
Learn MoreApply clinically grounded models to uncover disease drivers, biomarkers, and personalized therapeutic targets, connecting biological complexity to actionable patient care.
Learn MoreABOPM certification distinguishes physicians who are prepared to practice at the forefront of medicine where genomics, systems biology, and clinical insight converge to shape the future of care.
ABOPM membership connects you to exclusive resources, education, and collaboration opportunities designed to support long-term growth, leadership, and excellence in precision medicine.
The ABOPM Precision Oncology Department trains physicians to integrate tumor genomics, liquid biopsy, immunoprofiling, and targeted therapeutics into individualized treatment strategies — moving beyond population averages to treat each cancer as the unique disease it is.
Visit Department Page
Dr. Baser leads initiatives at the intersection of clinical oncology, tumor genomics, and precision therapeutics. He spearheads ABOPM's board-certified frameworks for biomarker-driven treatment selection, resistance mechanism interpretation, liquid biopsy monitoring, and adaptive precision therapy across solid tumors and hematologic malignancies.
Comprehensive Genomic Profiling
Somatic mutation analysis, copy number alterations, gene fusions, and mutational signatures across all tumor types.
Liquid Biopsy & ctDNA Monitoring
Real-time treatment response monitoring, minimal residual disease detection, and early resistance identification.
Immune Microenvironment Analysis
TMB, MSI status, PD-L1 expression, and TIL infiltration to identify immunotherapy responders.
Resistance Mechanism Mapping
Identifying acquired resistance pathways and adapting therapeutic strategy before clinical progression.
Identify actionable somatic mutations, copy number alterations, and gene fusions across every tumor site.
Guide institutional precision cancer programs and complex genomic treatment decisions.
Use ctDNA analysis to detect minimal residual disease and adapt therapy in real time.
Identify which patients respond to checkpoint inhibitors vs. combination or alternative immune strategies.
Every tumor has a molecular story.
Are you trained to read it?
Joining ABOPM is straightforward. Five steps stand between you and full access to the nation's leading precision medicine network.
Applicants must hold an active MD or DO license. ABOPM membership is currently restricted to licensed physicians to preserve the board's professional standards and ensure meaningful clinical collaboration across the network.
Submit your membership application online through the ABOPM member portal. The application is designed to be completed quickly, capturing the essential information needed to establish your physician profile within the network.
Provide your professional and licensing information for credential verification. This step ensures the integrity of the ABOPM physician directory and upholds the board's commitment to a trusted, professionally verified membership community.
Complete payment through our secure membership platform. Annual and monthly billing options are available across all membership tiers, giving you the flexibility to choose the structure that best suits your practice and professional goals.
Gain immediate access to all member benefits upon approval — including your digital membership certificate, full member portal access, physician directory listing, CME resources, clinical frameworks, and the complete ABOPM precision medicine network.
Membership is open to licensed MD and DO physicians. Begin your application today and gain immediate access to the education, credentials, and community that define the future of clinical medicine.
Explore ABOPM perspectives on genomics, multi-omics, systems thinking, clinical innovation, and the future of physician leadership in precision medicine.
Liquid biopsy is transforming cancer detection through minimally invasive genomic testing, offering new opportunities for earlier diagnosis and monitoring. ...more
Precision Oncology
June 05, 2026•9 min read
Polygenic risk scores may transform disease prediction, but gaps in genomic diversity continue to limit equity, accuracy, and access in precision medicine across global populations. ...more
Population Precision
May 26, 2026•9 min read
Artificial intelligence is reshaping precision medicine by improving diagnostics, predicting treatment response, and enabling more personalized, data-driven healthcare strategies. ...more
On the Frontier
May 20, 2026•9 min read
Subscribe to receive ABOPM insights, research updates, and educational resources delivered directly to your inbox.
© 2023-2025 American Board of Precision Medicine, Inc. All Rights Reserved.
